Dr Daryl Tan Clinic for Lymphoma, Myeloma and Blood Disorders

Services Offered

Dr. Daryl Tan’s haematology clinic, sghaematology.com, offers comprehensive services for patients with blood disorders and cancers. The clinic specializes in treating various conditions, including lymphoma (both Hodgkin and non-Hodgkin), multiple myeloma, and chronic lymphocytic leukemia (CLL). Their approach includes diagnosis, staging, risk stratification, and therapy for blood cancers. Treatment options range from chemotherapy and immunotherapy to counseling on clinical trials, both locally and internationally. They also manage clotting disorders, including administering and monitoring anticoagulation for conditions like deep vein thrombosis and pulmonary embolism, as well as reversing anticoagulation when necessary. Furthermore, they provide guidance for patients on anticoagulation undergoing surgical or dental procedures.

In addition to cancer and clotting-related services, the clinic addresses bleeding disorders such as immune thrombocytopenic purpura (ITP), haemophilia, and von Willebrand disease, including administering necessary blood products for treatment and prevention of bleeding. The clinic also handles general haematology issues, such as the diagnosis and treatment of anaemia, thrombocytopenia, and leucopenia. They treat autoimmune conditions causing low platelets or haemolytic anaemia with steroids and immunosuppression agents and manage bone marrow failure syndromes. Other services include transfusion of red blood cells and other blood products, as well as infusion of immunoglobulins for patients with immunodeficiencies. The clinic is committed to delivering personalized, high-quality care using the most up-to-date approaches.

Here’s a summary of the services in bullet points:

  • Blood Cancer/ Haemato-Oncology:
    • Treatment of lymphoma, multiple myeloma, acute and chronic leukaemias, myelodysplastic syndromes, myeloproliferative neoplasms, and other blood cancers.
    • Diagnosis, staging, risk stratification, and therapy of blood cancers, including inpatient and outpatient chemotherapy, immunotherapy, and counselling on clinical trials locally and internationally.
  • Clotting disorders:
    • Administration and monitoring of blood-thinning medicine (anticoagulation) in the treatment of blood clots like deep vein thrombosis and pulmonary embolism.
    • Reversal of anticoagulation in the event of severe bleeding.
    • Advice for patients on anticoagulation undergoing surgical and dental procedures.
  • Bleeding disorders:
    • Diagnosis of bleeding disorders like immune thrombocytopenic purpura (ITP), haemophilia, and von Willebrand disease.
    • Administration of necessary blood products for treatment and prevention of bleeding.
  • General Haematology:
    • Diagnosis and treatment of anaemia (low red blood cells), thrombocytopenia (low platelets), and leucopenia (low white blood cells).
    • Treatment of autoimmune conditions causing low platelets or haemolytic anaemia with steroids and immunosuppression agents.
    • Diagnosis and treatment of bone marrow failure syndromes.
    • Transfusion of red blood cells and other blood products.
    • Infusion of immunoglobulins for patients with immunodeficiencies.

Dr. Daryl Tan

MBBS, MRCP (UK), FAMS (Haematology)

Dr. Daryl Tan is a leading haematologist recognized for his expertise in lymphoma and multiple myeloma. He received the Singapore Government’s HMDP fellowship for advanced training at Stanford University and has played a key role in developing haematology services in Singapore. Currently a board member of the Chapter of Haematologists and an advisor for the national Haematology training program, Dr. Tan is also the Director of Research and managing partner at Raffles Cancer Centre.

He has successfully integrated clinical practice with research, contributing to over 100 high-impact publications, including lead-author articles in Lancet Oncology, Blood, and Annals of Oncology. Formerly leading lymphoma and myeloma services at Singapore General Hospital, he has driven numerous clinical trials and held academic and research roles, including Assistant Professor at Duke-NUS and recipient of multiple national research grants.